Skip to main content
HR 4812 116th Congress House Crime and Law Enforcement Administrative law and regulatory procedures Drug trafficking and controlled substances Licensing and registrations

Ensuring Compliance Against Drug Diversion Act of 2020

Introduced: October 23, 2019 Introduced by: Griffith, H. Morgan Republican · Virginia See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 16 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 18, 2020
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Nov 17, 2020
Motion to reconsider laid on the table Agreed to without objection.
Nov 17, 2020
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5819)
Nov 17, 2020
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5819)
Nov 17, 2020
DEBATE - The House proceeded with forty minutes of debate on H.R. 4812.
Nov 17, 2020
Considered under suspension of the rules. (consideration: CR H5819-5820)
Nov 17, 2020
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Nov 16, 2020
Placed on the Union Calendar, Calendar No. 482.
Nov 16, 2020
Committee on the Judiciary discharged.
Nov 16, 2020
Reported by the Committee on Energy and Commerce. H. Rept. 116-584, Part I.
Sep 9, 2020
Ordered to be Reported by Voice Vote.
Sep 9, 2020
Committee Consideration and Mark-up Session Held.
Nov 15, 2019
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Oct 26, 2019
Referred to the Subcommittee on Health.
Oct 23, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 23, 2019
Introduced in House
 Plain-English summary Congressional Research Service

Ensuring Compliance Against Drug Diversion Act of 2020

This bill provides statutory authority for certain regulations governing the modification, transfer, and termination of a registration to manufacture, distribute, or dispense controlled substances.

It terminates the registration of individuals and entities when they die, cease legal existence, discontinue business, or surrender such registration. It sets forth notification requirements, as well as conditions for transferring or assigning a registration.

What's happening now November 18, 2020

Received in the Senate and Read twice and referred to the Committee on the Judiciary.

 Committees of jurisdiction 5